This article was originally published on Opto – Invest in the Next Big Idea.
They have announced the launch of the Pegasus SPAC, which will take European financial companies public.
Arnault is France’s richest man and founder of luxury goods company LVMH [MC], a group which includes the Louis Vuitton, Dior, Givenchy and Veuve Clicquot brands. He is combining forces with Mustier, the ex-chief of UniCredit and Societe Generale’s investment banking arm, to create the new Pegasus SPAC. They are joined in the venture by French investment firm, Tikehau Capital, and former UniCredit and Bank of America “dealmaker” Diego De Giorgi.
Arnault’s personal holding company Financière Agache, Mustier, De Giorgi and Tikehau Capital will buy at least 10% of the Pegasus IPO between them, reports the Financial Times.
The Pegasus SPAC will focus on fintech, fund management, insurance and other diversified financial services across Europe, because these sectors have been identified as “ripe for consolidation because ultra-low interest rates, new regulations and technological advances have disrupted their business models”, as reported by the FT.
Will the Pegasus SPAC be the first of many?
SPACs are fast becoming a popular alternative to the traditional IPO path for private companies, especially in the US. Part of the appeal is that there is a lot less regulation, as well as “more certainty over the valuation that will be attained and funds raised”, according to Reuters’ Sudip Kar-Gupta.
Pegasus may herald increased popularity in so-called “blank-cheque companies” that focus on financial firms, with the FTnoting that a spate of current and former European bank CEOs are in the process of launching SPACs. Those announced so far include “former Credit Suisse chief executive, Tidjane Thiam, … former UBS chief Sergio Ermotti, ex-Commerzbank boss Martin Blessing and Barclays investment banker Makram Azar”.
Europe’s SPAC capital
Pegasus is amongst the first of an expected wave of SPACs to launch in Europe, and in Amsterdam more specifically.
Mustier certainly sees the appeal, telling theFT: “Europe needs more growth capital to support companies and the SPAC can be the missing instrument between a traditional IPO and private equity financing.”
The latest data from SPAC Research shows that 166 SPACs in the US have raised $52.1bn already in 2021 (as of 23 February). This is already more than half the number and value of SPACs in 2020 as a whole. Kar-Gupta reports that “concerns over a saturation of [the US] market [also] helped fuel the decision to list in Europe instead.”
The city is “emerging as the European capital for blank cheque companies”, according to the FT, as it benefits from a “shift of euro-denominated equity trading away from London since Brexit.”
Regulations in the Netherlands are also closest to the US, where “protections for SPAC investors are better than in many jurisdictions. For example, Dutch regulations allow investors to redeem their investment if the target eventually identified is not to their liking”, reports Reuters.
There are further reasons for selecting Amsterdam. Reutersreported a source close to the deal as saying: “We thought our proposal was differentiated by taking it to Europe, particularly when we are looking to target European companies … but we have looked to replicate a US structure so global investors understand it, and Amsterdam seemed best suited for that. … Amsterdam has taken over London in terms of [stock market] flows.”
With the Pegasus SPAC apparently the first of many, investors will be watching developments from this group of high-profile financiers with interest.
MyWallSt operates a full disclosure policy. MyWallSt staff currently hold long positions in companies mentioned above. Read our full disclosure policy here.
Leveraged ETFs are complex financial instruments that carry significant risks. Certain leveraged ETFs are only considered appropriate for experienced traders.
Disclaimer Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.
CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.
*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.
Guest Author at MyWallSt
The investment universe is changing beyond all recognition, and with a thematic focus, investors can capitalise on this wholesale disruption. From Genomics to Artificial Intelligence, disruptive innovation empowers companies to displace industry incumbents, and secure majority market share. Opto exists to identify those businesses, and help investors to invest in the next big idea.